Precision BioSciences (DTIL) has issued an update.
At Precision BioSciences’ annual meeting, stockholders approved an amendment to increase the number of shares available under the 2019 Incentive Award Plan by 630,000, with additional annual increments until 2029. The meeting saw the election of Stanley R. Frankel, M.D., and Samuel Wadsworth, Ph.D. as Class II directors, the ratification of Deloitte & Touche LLP as the independent auditors for 2024, and approval for adjourning the meeting if necessary to gain sufficient votes for proposal approvals. These decisions reflect the company’s commitment to growth and governance, signaling potential interest for investors.
Find detailed analytics on DTIL stock on TipRanks’ Stock Analysis page.
